VERAVAS, Inc.

📍 Austin, United States🗓 Founded 2017👥 20 employees💰 Last funded Jul 2019
Medical and Diagnostic Laboratories🌐 veravas.com
Website LinkedIn
Veravas is a leading innovator in clinical diagnostics focused on the early-stage detection of Alzheimer’s disease and other neurological conditions. The company’s proprietary VeraBIND™ technology transforms challenging sample types into measurable biomarkers, enabling earlier disease detection and the development of novel diagnostic tests. Its VeraBIND Tau assay is a first-in-class blood-based test that measures the pathological activity of hyperphosphorylated tau in blood samples of cognitively normal individuals or individuals experiencing cognitive impairment which may be used to aid in the diagnosis of Alzheimers disease.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2017
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in VERAVAS, Inc.?
VERAVAS, Inc. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did VERAVAS, Inc. last raise funding?
The most recent investment in VERAVAS, Inc. recorded on gritt.io was in July 2019.
When was VERAVAS, Inc. founded?
VERAVAS, Inc. was founded in 2017.
What industry is VERAVAS, Inc. in?
VERAVAS, Inc. operates in Medical and Diagnostic Laboratories. Find similar Medical and Diagnostic Laboratories investors on gritt.io.
Where is VERAVAS, Inc. based?
VERAVAS, Inc. is headquartered in Austin, United States.